Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.80%
#2 Movement Movement +11.34%
#3 Victoria VR Victoria VR +7.37%
#4 DMT-NAT DMT-NAT +5.95%
#5 Cryptopia Cryptopia +5.23%
#6 COTI COTI +4.96%
#7 Lisk Lisk +4.73%
#8 Pons Pons +4.67%
#9 MarsCoin MarsCoin +4.33%
#10 Jito Jito +3.85%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
設定
言語
日本
通貨
USD
テーマ
SK3 Group, Inc. SK3 Group, Inc.

SK3 Group, Inc.

SKTO
株式のランク #42239
SK3 Group, Inc. offers strategic consulting, product authorization, and... SK3 Group, Inc. offers strategic consulting, product authorization, and promotional assistance to medical cannabis organizations situated in California. The company also grants licenses for the commercialization and distribution of a varied range of products. These include the YAK brand of medical marijuana edibles; Canna-Loz, an ingestion method for significant quantities of phyto-cannabinoids; Yeti, a pre-rolled item crafted for pain management; and Dharmanol, an exclusive technological process that isolates, stabilizes, and safeguards the beneficial cannabinoids from hemp and marijuana in their non-intoxicating form. Previously operating as CTT International Distributors, Inc., the company officially rebranded as SK3 Group, Inc. in May 2007. Founded in 2000, its main corporate base is located in Los Angeles, California. SK3 Group, Inc. is an affiliate of Healthcare of Today, Inc.
株価
$0.00001
最終同期: 2026-08-11
時価総額
$3.02K
変化（1日）
0.00%
変化（1年）
-98.00%
国
US
取引 SK3 Group, Inc. (SKTO)

カテゴリー

Healthcare
SK3 Group, Inc.（SKTO）のP/B比率
2026 時点のP/B比率 TTM: 0
SK3 Group, Inc. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
SK3 Group, Inc. の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE